menu ☰
menu ˟

FDA orders label change allowing some alcohol use with flibanserin

12 Apr 2019
The FDA on Thursday issued a safety labeling change order to Sprout Pharmaceuticals for the serotonin receptor agonist flibanserin, ordering a modification to the boxed warning that states alcohol use is contraindicated when taking the drug.The revis...

Click here to view the full article which appeared in Endocrinology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.